399 results ECJ in Unilever: commercial policy by dominant undertakings on thin ice Unilever shows the need to assess evidence on lack of anti-competitive effects in abuse cases and how liability can extend across different levels of the supply chain. Dominant undertakings had better think twice when imposing policy on distributors. Sense and sensibility in sustainability collaborations The ACMâs push for companies to come forward for an antitrust blessing of their sustainability solutions is paying off. The ACM has again given informal guidance to companies wishing to make sustainability agreements. Enforcement of open, sustainability-oriented CSDDD standards: lessons from administrative law Tom Barkhuysen and ValĂ©rie van 't Lam wrote a preliminary opinion for the Koninklijke Vereeniging 'Handelsrecht' on how to enforce the CSDDD's open standards. Handhaving van open, op duurzaamheid gerichte CSDDD-normen: lessen uit het bestuursrecht Tom Barkhuysen en ValĂ©rie van 't Lam schreven voor de Koninklijke Vereeniging 'Handelsrecht' een preadvies over de handhaving van de open normen van de CSDDD. Spooked no more: antitrust safe harbour for solo self-employed persons The Commissionâs guidelines on collective agreements clarify the manoeuvre room solo self-employed persons have under the competition rules to collectively boost their working conditions. A Directive on platform work working conditions is on the way. ESG gaat alle facetten van de onderneming raken Onze collega's breken een lans om goed geĂŻnformeerd uit te stijgen boven compliance met ESG-wet- en regelgeving, zodat in alle zorgvuldigheid verantwoordelijkheid kan worden genomen voor het ontwikkelen van een duurzame strategie. The latest Legal Updates straight to your mailbox We publish high-quality legal knowledge and insights on our website on a daily basis. If you would like to be promptly informed about the latest developments within your areas of interest, we invite you to sign up for our Legal Updates. De laatste Legal Updates direct in uw mailbox Dagelijks publiceren wij op onze website hoogwaardige juridische kennis en vooruitzichten. Wilt u snel op de hoogte zijn van de meest actuele ontwikkelingen binnen uw interessegebieden? Meld u dan aan voor onze Legal Updates. Top tips for doing capital markets deals in the Netherlands Nora Offergelt and Pieter SchĂŒtte have written a Practice Note with Practical Law Capital Markets in which they discuss the top tips for doing capital markets deals in the Netherlands. ESG and potential directorâs liability: taking the lead in the transition to more sustainable business operations There is a lot coming at companies with regard to sustainability matters these days. This could also affect company directorsâ responsibilities and liability. In this article, we will discuss some points of attention and share our practical observations. ESG risk management: developments in the Dutch and EU financial sector What ESG risk rules are coming for EU/Dutch financial firms? DNBâs new climate risk Guide for insurers, pension funds, and payment firms aligns with EBA ESG Guidelines. This blog explains how both shape the future of EU ESG risk management. FSR zorgt voor nieuwe uitdagingen bij transacties en aanbestedingen Op 12 januari van dit jaar trad de Foreign Subsidies Regulation (FSR) in werking, die per 12 oktober een meldplicht bij de Europese Commissie voor bepaalde transacties en aanbestedingen introduceert. Dutch national security screening regime enters into force The Dutch national security screening regime (Wet veiligheidstoets investeringen, fusies en overnames or Wet Vifo) enters into force today, 1 June. Levelling the playing field in 2023: new tools and hurdles While 2022 revolved around new and improved regulatory tools, the focus in 2023 will be on putting these tools to use. More merger-related obligations, digital sector scrutiny and clarity on competition-law and consumer-law aspects is imminent. The EU Artificial Intelligence Act: our 16 key takeaways The AI Act is the first comprehensive AI regulation in the world. In this first episode of our Artificial Intelligence series, we have set out our initial key takeaways on the AI Act based on the text as currently approved by the Council of the EU. The long and (un)winding road of âkiller acquisitionâ Illumina/Grail Crystal ball gazing into prospective innovation rat races when assessing vertical mergers may soon be all in a dayâs work for the European Commission. Innovation was a recurring theme in the Commissionâs handling of the Illumina/Grail deal. If you have nothing nice to sayâŠTeva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and âdivisional gamingâ to delay market entry and hinder the uptake of a competing drug. The ECJâs ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines. Pagination Previous page Page 13 Current page 14 Page 15 Page 16 Next page
ECJ in Unilever: commercial policy by dominant undertakings on thin ice Unilever shows the need to assess evidence on lack of anti-competitive effects in abuse cases and how liability can extend across different levels of the supply chain. Dominant undertakings had better think twice when imposing policy on distributors.
Sense and sensibility in sustainability collaborations The ACMâs push for companies to come forward for an antitrust blessing of their sustainability solutions is paying off. The ACM has again given informal guidance to companies wishing to make sustainability agreements.
Enforcement of open, sustainability-oriented CSDDD standards: lessons from administrative law Tom Barkhuysen and Valérie van 't Lam wrote a preliminary opinion for the Koninklijke Vereeniging 'Handelsrecht' on how to enforce the CSDDD's open standards.
Handhaving van open, op duurzaamheid gerichte CSDDD-normen: lessen uit het bestuursrecht Tom Barkhuysen en Valérie van 't Lam schreven voor de Koninklijke Vereeniging 'Handelsrecht' een preadvies over de handhaving van de open normen van de CSDDD.
Spooked no more: antitrust safe harbour for solo self-employed persons The Commissionâs guidelines on collective agreements clarify the manoeuvre room solo self-employed persons have under the competition rules to collectively boost their working conditions. A Directive on platform work working conditions is on the way.
ESG gaat alle facetten van de onderneming raken Onze collega's breken een lans om goed geĂŻnformeerd uit te stijgen boven compliance met ESG-wet- en regelgeving, zodat in alle zorgvuldigheid verantwoordelijkheid kan worden genomen voor het ontwikkelen van een duurzame strategie.
The latest Legal Updates straight to your mailbox We publish high-quality legal knowledge and insights on our website on a daily basis. If you would like to be promptly informed about the latest developments within your areas of interest, we invite you to sign up for our Legal Updates.
De laatste Legal Updates direct in uw mailbox Dagelijks publiceren wij op onze website hoogwaardige juridische kennis en vooruitzichten. Wilt u snel op de hoogte zijn van de meest actuele ontwikkelingen binnen uw interessegebieden? Meld u dan aan voor onze Legal Updates.
Top tips for doing capital markets deals in the Netherlands Nora Offergelt and Pieter SchĂŒtte have written a Practice Note with Practical Law Capital Markets in which they discuss the top tips for doing capital markets deals in the Netherlands.
ESG and potential directorâs liability: taking the lead in the transition to more sustainable business operations There is a lot coming at companies with regard to sustainability matters these days. This could also affect company directorsâ responsibilities and liability. In this article, we will discuss some points of attention and share our practical observations.
ESG risk management: developments in the Dutch and EU financial sector What ESG risk rules are coming for EU/Dutch financial firms? DNBâs new climate risk Guide for insurers, pension funds, and payment firms aligns with EBA ESG Guidelines. This blog explains how both shape the future of EU ESG risk management.
FSR zorgt voor nieuwe uitdagingen bij transacties en aanbestedingen Op 12 januari van dit jaar trad de Foreign Subsidies Regulation (FSR) in werking, die per 12 oktober een meldplicht bij de Europese Commissie voor bepaalde transacties en aanbestedingen introduceert.
Dutch national security screening regime enters into force The Dutch national security screening regime (Wet veiligheidstoets investeringen, fusies en overnames or Wet Vifo) enters into force today, 1 June.
Levelling the playing field in 2023: new tools and hurdles While 2022 revolved around new and improved regulatory tools, the focus in 2023 will be on putting these tools to use. More merger-related obligations, digital sector scrutiny and clarity on competition-law and consumer-law aspects is imminent.
The EU Artificial Intelligence Act: our 16 key takeaways The AI Act is the first comprehensive AI regulation in the world. In this first episode of our Artificial Intelligence series, we have set out our initial key takeaways on the AI Act based on the text as currently approved by the Council of the EU.
The long and (un)winding road of âkiller acquisitionâ Illumina/Grail Crystal ball gazing into prospective innovation rat races when assessing vertical mergers may soon be all in a dayâs work for the European Commission. Innovation was a recurring theme in the Commissionâs handling of the Illumina/Grail deal.
If you have nothing nice to sayâŠTeva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and âdivisional gamingâ to delay market entry and hinder the uptake of a competing drug.
The ECJâs ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines.